Journals / İstanbul Medical Journal / 2019 / Cilt: 20 - Sayı: 4

The Relationship Between Disease Activity, Vegf, E-selectin Levels and Arterial Stiffness in Patients with Rheumatic Diseases

Romatizmal Hastalığı Bulunan Hastalarda Arteriyel Sertlik, Vegf ve E-selektin Düzeyi ile Hastalık Aktivitesi Arasındaki İlişki

Pages
285–288
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The data were statistically evaluated byusing Student t-test, Mann-Whitney U Test and Wilcoxon test.Results: DAS-28, BASDAI, ESR and CRP levels were significantlydecreased on the 3rd month of treatment in all patients(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The endothelial damage, changes in vascularpermeability and plaque formation are caused by the effectsof cytokines and chemokines that plays role in chronicinflammation in rheumatoid arthritis (RA) and ankylosingspondylitis (AS).
📊
Key Findings & Data:In this study, we aimed to determine therelationship between vascular endothelial growth factor (VEGF),E-selectin, arterial stiffness and disease activity in patients withrheumatic diseases.Methods: Thirteen patients diagnosed with AS, 28 patientsdiagnosed with RA and 30 healthy controls were includedin the study.
💡
Conclusion & Impact:The data were statistically evaluated byusing Student t-test, Mann-Whitney U Test and Wilcoxon test.Results: DAS-28, BASDAI, ESR and CRP levels were significantlydecreased on the 3rd month of treatment in all patients(p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The endothelial damage, changes in vascularpermeability and plaque formation are caused by the effectsof cytokines and chemokines that plays role in chronicinflammation in rheumatoid arthritis (RA) and ankylosingspondylitis (AS). It has been reported that arterial stiffnessand the level of cell adhesion molecules are affected byinflammation. In this study, we aimed to determine therelationship between vascular endothelial growth factor (VEGF),E-selectin, arterial stiffness and disease activity in patients withrheumatic diseases.Methods: Thirteen patients diagnosed with AS, 28 patientsdiagnosed with RA and 30 healthy controls were includedin the study. Arterial stiffness, VEGF, E-selectin, erythrocytesedimentation rate (ESR) and C-reactive protein (CRP) wereevaluated in all patients and healthy controls. Bath AnkylosingSpondylitis Disease Activity Index (BASDAI) and Disease ActivityScore-28 (DAS-28) were calculated in patients with rheumaticdiseases. The level of serum VEGF and E-selectin weredetermined by ELISA, and arterial stiffness was measured byoscillometric method. The data were statistically evaluated byusing Student t-test, Mann-Whitney U Test and Wilcoxon test.Results: DAS-28, BASDAI, ESR and CRP levels were significantlydecreased on the 3rd month of treatment in all patients(p

Özet

Amaç: Romatoid artrit (RA) ve anklozan spondilitte (AS) endotel hasarı, damar geçirgenliğinde değişim, plak oluşumu kronik enflamasyonda rolleri olan sitokin ve kemokinlerin etkisi ile olmaktadır. Yapılan çalışmalarda enflamasyon düzeyi ile arteryel sertlik ve hücre adezyon molekül miktarında değişim olduğu bildirilmiştir. Bu çalışmada, romatizmal hastalığı olan hastalarda vasküler endotel büyüme faktörü (VEGF), E-selectin, arteriyel sertlik ve hastalık aktivitesi arasındaki ilişkiyi belirlemeyi amaçladık. Yöntemler: Çalışmamıza AS tanılı 13 hasta, RA tanılı 28 hasta ve 30 sağlıklı kontrol dahil edildi. Tüm hasta ve sağlıklı kontrol grubunda arteriyel sertlik, VEGF ve E-selektin, eritrosit sedimentasyon hızı (ESH) ve CRP düzeylerine bakıldı. Romatizmal hastalığı bulunan grupta hastalık aktivite göstergeleri olan Banyo Ankilozan Spondilit Hastalığı Aktivite İndeksi (BASDAİ) ve DAS-28 skorları hesaplandı. Serum VEGF ve E-selektin ölçümü ELISA yöntemi ile, arteriyel sertlik ölçümü ise osilometrik metotla bakıldı. Elde edilen veriler Student t-testi, Mann-Whitney U testi ve Wilcoxon testi ile istatistiksel olarak karşılaştırıldı. Bulgular: Tüm hasta gruplarında tedavi sonrasında 3. ayda DAS-28, BASDAİ skorları, ESH ve CRP düzeylerinde anlamlı bir azalma olduğu gözlenmiştir (p

🔖

Cite This Article

AKDAM, H., BAYGIN, H., YILMAZ, M., ŞENTÜRK, T., SARGIN, G. (2022). The Relationship Between Disease Activity, Vegf, E-selectin Levels and Arterial Stiffness in Patients with Rheumatic Diseases. İstanbul Medical Journal, Cilt: 20 - Sayı: 4, 285–288. https://ajindex.com/articles/551931

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nat Rev Rheumatol 2015; 11: 390-400
  2. Crowson CS, Liao KP, Davis JM 3rd, Solomon DH, Matteson EL, Knutson KL, et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J 2013; 16: 622-8
  3. Genre F, López-Mejías R, Miranda-Filloy JA, Ubilla B, Carnero-López B, Blanco R, et al. Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis. Biomed Res Int 2014; 2014: 860651
  4. Teixeira R, Vieira MJ, Gonçalves A, Cardim N, Gonçalves L. Ultrasonographic vascular mechanics to assess arterial stiffness: a review. Eur Heart J Cardiovasc Imaging 2016; 17: 233-46
  5. Mathieu S, Joly H, Baron G, Tournadre A, Dubost JJ, Ristori JM, et al. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology (Oxford) 2008; 47: 1203-7
  6. Crafts TD, Jensen AR, Blocher-Smith EC, Markel TA. Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia. Cytokine 2015; 71: 385-93
  7. Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012; 8: 390-8
  8. Jubeli E, Moine L, Vergnaud-Gauduchon J, Barratt G. E-selectin as a target for drug delivery and molecular imaging. J Control Release 2012; 158: 194-206
  9. Schneider M, Krüger K. Rheumatoid arthritis--early diagnosis and disease management. Dtsch Arztebl Int 2013; 110: 477-84
  10. Ghasemi-Rad M, Attaya H, Lesha E, Vegh A, Maleki-Miandoab T, Nosair E, et al. Ankylosing spondylitis: A state of the art factual backbone. World J Radiol 2015; 7: 236-52
  11. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 4149-56
  12. Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T, et al. Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 1998; 27: 377-80
  13. Drouart M, Saas P, Billot M, Cedoz JP, Tiberghien P, Wendling D, et al. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol 2003; 132: 158-62
  14. Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, et al. Inflammatory biomarkers, disease activity and